Vivani Medical prices $16M offering at $1.62 per share

* Clinical-stage biopharmaceutical company Vivani Medical (NASDAQ:VANI [https://seekingalpha.com/symbol/VANI]) priced [https://seekingalpha.com/pr/20279638-vivani-medical-inc-announces-pricing-of-common-stock-offering] a registered direct offering of 6M shares of its common stock at an offering price of $1.62 per share and concurrent private placement of ~3.7M shares at an offering price of $1.62 per share purchased by Gregg Williams, the chairman of the company’s board of directors.
* The registered offering and the private placement were priced “at-the-market” under the rules and regulations of Nasdaq.
* The gross proceeds to the company from the registered offering and private placement are expected to be ~$15.7 million.
* The registered offering and private placement are expected to close on or about October 28, 2025.
* Net proceeds are expected to fund ongoing research and clinical development of the company’s product candidates, as well as for working capital and general corporate purposes.

MORE ON VIVANI MEDICAL

* Seeking Alpha’s Quant Rating on Vivani Medical [https://seekingalpha.com/symbol/VANI/ratings/quant-ratings]
* Historical earnings data for Vivani Medical [https://seekingalpha.com/symbol/VANI/earnings]
* Financial information for Vivani Medical [https://seekingalpha.com/symbol/VANI/income-statement]